Brenda Mann

Insider Reports History

Entity
Individual
Location
C/O Eyegate Pharmaceuticals, Inc., 271 Waverly Oaks Road, Suite 108, Waltham, MA
Signature
/s/ Sarah Romano, Attorney-in-Fact*
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brenda Mann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EYEGATE PHARMACEUTICALS INC VP of Research & Development Common Stock 15.1K $58K $3.83 Nov 2, 2021 Direct

Insider Reports Filed by Brenda Mann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPRX EYEGATE PHARMACEUTICALS INC Nov 2, 2021 1 -$123 4 Nov 3, 2021 VP of Research & Development
KPRX EYEGATE PHARMACEUTICALS INC Oct 4, 2021 1 -$125 4 Oct 5, 2021 VP of Research & Development
KPRX EYEGATE PHARMACEUTICALS INC Sep 2, 2021 1 -$110 4 Sep 3, 2021 VP of Research & Development
KPRX EYEGATE PHARMACEUTICALS INC Aug 3, 2021 1 -$151 4 Aug 4, 2021 VP of Research & Development
KPRX EYEGATE PHARMACEUTICALS INC Jul 2, 2021 1 -$570 4 Jul 6, 2021 VP of Research & Development
KPRX EYEGATE PHARMACEUTICALS INC Jun 4, 2021 1 -$649 4 Jun 7, 2021 VP of Research & Development